rhodioloside has been researched along with Diabetic Angiopathies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Hu, R; Liu, LY; Lu, L; Ni, SH; Wang, M; Wang, MQ; Wang, YJ; Wei, LB; Wu, XH; You, HY | 1 |
1 other study(ies) available for rhodioloside and Diabetic Angiopathies
Article | Year |
---|---|
Salidroside ameliorates endothelial inflammation and oxidative stress by regulating the AMPK/NF-κB/NLRP3 signaling pathway in AGEs-induced HUVECs.
Topics: AMP-Activated Protein Kinases; Cell Line; Diabetic Angiopathies; Endothelium, Vascular; Glucosides; Glycation End Products, Advanced; Human Umbilical Vein Endothelial Cells; Humans; Inflammasomes; Inflammation; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Phenols; Reactive Oxygen Species; RNA-Seq; Signal Transduction; Transcription Factor RelA | 2020 |